You are not logged in. | Log in

SIDRA

GXB

Clear Search
Updating...
Gene Symbol: --
Signal: --
Sample ID: --
Full Name--
Summary--
Links
Pubmed Articles --
User Notes --
Description

ER+, adjuvant tamoxifen, early stage

Purpose

This external validation set was kindly provided by the Guy's Hospital, London, United Kingdom, consisting of 77 patients diagnosed with early stage breast cancer and treated with adjuvant tamoxifen monotherapy. Samples were hybridized using Affymetrix U133PLUS2 Genechips™ according to standard Affymetrix protocols. Gene expression values from the CEL were normalized by use of the standard quantile normalization method in RMA.

Hypothesis

Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen.

Experimental Design

ER+ , adjuvant tamoxifen monotherapy , early stage breast cancer

Platform Affymetrix HG-U133_Plus_2
No information available.
Default files:

Signal Data File

Download Annotations for Group Set:
Download Annotations for Group:
Download Ranklist:
Additional Files:

(Uploaded through the Files tab in the Annotation Tool)

GSE9195_appended.meta.data_v1.csv

Your email has been sent!
Advanced
Yes No
Yes No
X-axis Y-axis Both None
Yes No
Rank Lists
Group Set
Sort By
      Bar Plot Box Plot
    Overlays
      Updating...
      Your bug report has been sent!
      Sample Set Level   Dataset Level   Gene Level
      Your note has been added
      Loading...